OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs
Timo W. M. De Groof, Vladimir Bobkov, Raimond Heukers, et al.
Molecular and Cellular Endocrinology (2019) Vol. 484, pp. 15-24
Open Access | Times Cited: 53
Timo W. M. De Groof, Vladimir Bobkov, Raimond Heukers, et al.
Molecular and Cellular Endocrinology (2019) Vol. 484, pp. 15-24
Open Access | Times Cited: 53
Showing 26-50 of 53 citing articles:
Class A and C GPCR Dimers in Neurodegenerative Diseases
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10
Semi‐synthetic nanobody‐ligand conjugates exhibit tunable signaling properties and enhanced transcriptional outputs at neurokinin receptor‐1
Nayara Braga Emídio, Ross W. Cheloha
Protein Science (2023) Vol. 33, Iss. 2
Open Access | Times Cited: 6
Nayara Braga Emídio, Ross W. Cheloha
Protein Science (2023) Vol. 33, Iss. 2
Open Access | Times Cited: 6
GPCR Activation States Induced by Nanobodies and Mini-G Proteins Compared by NMR Spectroscopy
Philip Rößler, Daniel Mayer, Ching‐Ju Tsai, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5984-5984
Open Access | Times Cited: 15
Philip Rößler, Daniel Mayer, Ching‐Ju Tsai, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5984-5984
Open Access | Times Cited: 15
Anti-EGFR Binding Nanobody Delivery System to Improve the Diagnosis and Treatment of Solid Tumours
Long Wang, Gengyuan Zhang, Long Qin, et al.
Recent Patents on Anti-Cancer Drug Discovery (2020) Vol. 15, Iss. 3, pp. 200-211
Closed Access | Times Cited: 14
Long Wang, Gengyuan Zhang, Long Qin, et al.
Recent Patents on Anti-Cancer Drug Discovery (2020) Vol. 15, Iss. 3, pp. 200-211
Closed Access | Times Cited: 14
The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy
Géraldine Schlecht‐Louf, Claire Deback, Françoise Bachelerie
Cancers (2022) Vol. 14, Iss. 3, pp. 848-848
Open Access | Times Cited: 8
Géraldine Schlecht‐Louf, Claire Deback, Françoise Bachelerie
Cancers (2022) Vol. 14, Iss. 3, pp. 848-848
Open Access | Times Cited: 8
Generation and characterization of nanobodies targeting GPCR
Shenglan Zhang, Zhiran Fan, Jianfeng Liu
Biophysics Reports (2024) Vol. 10, Iss. 1, pp. 22-22
Open Access | Times Cited: 1
Shenglan Zhang, Zhiran Fan, Jianfeng Liu
Biophysics Reports (2024) Vol. 10, Iss. 1, pp. 22-22
Open Access | Times Cited: 1
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism
Stephanie M. Anbuhl, Xavier Dervillez, Saskia Neubacher, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116457-116457
Open Access | Times Cited: 1
Stephanie M. Anbuhl, Xavier Dervillez, Saskia Neubacher, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116457-116457
Open Access | Times Cited: 1
Nanobody-as Versatile Tool Emerging in Autoimmune Diseases
Ling Wang, Ran Luo, Wenkang Zhang, et al.
Smart Materials in Medicine (2024)
Open Access | Times Cited: 1
Ling Wang, Ran Luo, Wenkang Zhang, et al.
Smart Materials in Medicine (2024)
Open Access | Times Cited: 1
A Cell-free Expression Pipeline for the Generation and Functional Characterization of Nanobodies
Lisa Haueis, Marlitt Stech, Stefan Kubick
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 7
Lisa Haueis, Marlitt Stech, Stefan Kubick
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 7
Recent progress in antitumor functions of the intracellular antibodies
Yunfeng Lin, Zhuo Chen, Chaohua Hu, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 6, pp. 1109-1120
Closed Access | Times Cited: 10
Yunfeng Lin, Zhuo Chen, Chaohua Hu, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 6, pp. 1109-1120
Closed Access | Times Cited: 10
Finding the Perfect Fit: Conformational Biosensors to Determine the Efficacy of GPCR Ligands
Keith M. Olson, Andra Campbell, Andrew Alt, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 9, pp. 694-709
Open Access | Times Cited: 6
Keith M. Olson, Andra Campbell, Andrew Alt, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 9, pp. 694-709
Open Access | Times Cited: 6
Optical sensors of heterotrimeric G protein signaling
Alexey Bondar, Josef Lazar
FEBS Journal (2020) Vol. 288, Iss. 8, pp. 2570-2584
Open Access | Times Cited: 7
Alexey Bondar, Josef Lazar
FEBS Journal (2020) Vol. 288, Iss. 8, pp. 2570-2584
Open Access | Times Cited: 7
Membrane dynamics are slowed for Alexa594-labeled membrane proteins due to substrate interactions
Alan W. Weisgerber, Michelle K. Knowles
BBA Advances (2021) Vol. 1, pp. 100026-100026
Open Access | Times Cited: 6
Alan W. Weisgerber, Michelle K. Knowles
BBA Advances (2021) Vol. 1, pp. 100026-100026
Open Access | Times Cited: 6
Arrestin and G Protein Interactions with GPCRs: A Structural Perspective
Carlos A.V. Barreto, Salete J. Baptista, Beatriz Bueschbell, et al.
(2022), pp. 109-179
Closed Access | Times Cited: 4
Carlos A.V. Barreto, Salete J. Baptista, Beatriz Bueschbell, et al.
(2022), pp. 109-179
Closed Access | Times Cited: 4
New insights into the functional impact of G protein–coupled receptor oligomerization
Gillian P. Johnson, Uche Agwuegbo, Kim Jonas
Current Opinion in Endocrine and Metabolic Research (2020) Vol. 16, pp. 43-50
Closed Access | Times Cited: 5
Gillian P. Johnson, Uche Agwuegbo, Kim Jonas
Current Opinion in Endocrine and Metabolic Research (2020) Vol. 16, pp. 43-50
Closed Access | Times Cited: 5
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies
Claudia V. Perez Almeria, Omolade Otun, Roman R. Schlimgen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Claudia V. Perez Almeria, Omolade Otun, Roman R. Schlimgen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Semi-synthetic nanobody-ligand conjugates exhibit tunable signaling properties and enhanced transcriptional outputs at neurokinin receptor-1
Nayara Braga Emídio, Ross W. Cheloha
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Nayara Braga Emídio, Ross W. Cheloha
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Exploring the use of intracellular and extracellular allosteric modulators to understand GPCR signaling
Kyla Bourque, Juliana C.C. Dallagnol, Hassan Nassour, et al.
Elsevier eBooks (2022), pp. 135-160
Closed Access | Times Cited: 2
Kyla Bourque, Juliana C.C. Dallagnol, Hassan Nassour, et al.
Elsevier eBooks (2022), pp. 135-160
Closed Access | Times Cited: 2
Yuh‐Jiin I. Jong, Steven K. Harmon, Karen L. O’Malley
(2022), pp. 216-298
Closed Access | Times Cited: 2
Monitoring ligand-induced changes in receptor conformation with NanoBiT conjugated nanobodies
Mark Soave, Raimond Heukers, Barrie Kellam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
Mark Soave, Raimond Heukers, Barrie Kellam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
Targeting the latent human cytomegalovirus reservoir with virus specific nanobodies
Timo W. M. De Groof, Elizabeth Elder, Raimond Heukers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
Timo W. M. De Groof, Elizabeth Elder, Raimond Heukers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
Current pivotal strategies leading a difficult target protein to a sample suitable for crystallographic analysis
Atsuko Yamashita
Biochemical Society Transactions (2020) Vol. 48, Iss. 4, pp. 1661-1673
Closed Access | Times Cited: 1
Atsuko Yamashita
Biochemical Society Transactions (2020) Vol. 48, Iss. 4, pp. 1661-1673
Closed Access | Times Cited: 1
In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates
Irati Beltrán Hernández, Timo W. M. De Groof, Raimond Heukers, et al.
Methods in molecular biology (2022), pp. 505-520
Closed Access | Times Cited: 1
Irati Beltrán Hernández, Timo W. M. De Groof, Raimond Heukers, et al.
Methods in molecular biology (2022), pp. 505-520
Closed Access | Times Cited: 1
Current Trends of Electrochemical Sensing for Mycotoxins
Ruchika Chauhan, Rashi Bhardwaj, Sheetal K. Bharadwaj, et al.
Concepts and strategies in plant sciences (2021), pp. 275-323
Closed Access | Times Cited: 1
Ruchika Chauhan, Rashi Bhardwaj, Sheetal K. Bharadwaj, et al.
Concepts and strategies in plant sciences (2021), pp. 275-323
Closed Access | Times Cited: 1
Using NanoB2 to gain insights into ligand pharmacology
Xinchao Shi, Jian Zhang
Cell Reports Methods (2023) Vol. 3, Iss. 3, pp. 100438-100438
Open Access
Xinchao Shi, Jian Zhang
Cell Reports Methods (2023) Vol. 3, Iss. 3, pp. 100438-100438
Open Access
